Cognition Therapeutics, Inc. (CGTX) Free cash flow 2021–2025
Cognition Therapeutics, Inc. (CGTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$24.6MFY2025 · since FY2021: -$3.6M → -$24.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.6M | +14.1% |
| FY2024 | -$28.6M | -76.8% |
| FY2023 | -$16.2M | +12.8% |
| FY2022 | -$18.6M | -409.8% |
| FY2021 | -$3.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice